Tomato concentrate could help reduce chronic intestinal inflammation associated with HIV

Credit: Pixabay/CC0 Public Domain

New UCLA-led research in mice suggests that adding a certain type of tomato concentrate to the diet can reduce the intestinal inflammation that is associated with HIV. Left untreated, intestinal inflammation can accelerate arterial disease, which in turn can lead to heart attack and stroke.

The findings provide clues to how the altered intestinal tract affects disease-causing inflammation in people with chronic HIV infection, suggesting that targeting the inflamed intestinal wall may be a novel way to prevent the systemic inflammation that persists even when antiviral therapy is effective in controlling a person’s HIV.

The study is published in the peer-reviewed journal PLOS Pathogens.

“Inflammation is an important process that protects the body from invading infections and toxins,” said Dr. Theodoros Kelesidis, the paper’s senior author and an associate professor of medicine in the division of infectious diseases at the David Geffen School of Medicine at UCLA. “But in individuals who are successfully treated for HIV to the point that their viral load is no longer detectable, the continuing low-grade inflammation in the cells of the intestine contributes to an increased risk of or stroke.”

People with HIV have been found to have a condition called “,” in which products in the gut bacteria, such as lipopolysaccharides, move to other parts of the body through the bloodstream. Those products promote systemic inflammation and can accelerate coronary disease, Kelesidis said.

The researchers worked with mice that had been infected with HIV and whose immune systems had been altered to mimic those of humans. The mice were fed a diet containing the tomato concentrate Tg6F, while the rest were fed a normal diet for mice—low in fat, cholesterol and calories.

Tg6F comes from a specific type of genetically modified tomato; it contains anti-inflammatory and antioxidant peptides called apoA-I mimetic peptides, which imitate the main protein in HDL, the so-called “good cholesterol.”

The researchers examined proteins called cytokines and chemokines that are known to predict intestinal and blood inflammation, which can augur adverse outcomes for people with chronic HIV infection.

They found that mice that were given Tg6F had lower levels of pro- and chemokines in their gut and blood than the mice that received the standard diet. In addition, they discovered that Tg6F prevented an increase in levels of a protein called ADAM17, which orchestrates inflammatory responses in people with chronic HIV infection. The investigators confirmed the anti-inflammatory effects of apoA-I mimetics in gut biopsies from people with HIV.

“Targeting the inflamed intestine with the peptide that mimics the main protein in HDL may be a way of preventing systemic inflammation in people with chronic HIV,” Kelesidis said. “Giving oral apoA-I mimetics together with oral antivirals may be an attractive novel therapy to treat inflammation and prevent disease and death in HIV.”

The authors note in the paper that mice cannot fully recreate all aspects of humans’ HIV infection. Also, the gut biopsies used to test the effects of apoA-I mimetics do not fully reflect how inflammation works within a living human body.


Is the relationship between diet, intestinal bacteria and cells key to preventing systemic inflammation?


More information:
Maria Daskou et al, ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV, PLOS Pathogens (2022). DOI: 10.1371/journal.ppat.1010160

Citation:
Tomato concentrate could help reduce chronic intestinal inflammation associated with HIV (2022, January 11)
retrieved 11 January 2022
from https://medicalxpress.com/news/2022-01-tomato-chronic-intestinal-inflammation-hiv.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Source link

Leave a Reply

Health News

Study finds cancer immunotherapy treatment can reverse HIV latency

Credit: Pixabay/CC0 Public Domain An international research collaboration has found the cancer immunotherapy treatment, pembrolizumab, can reverse HIV latency, the ability for the virus to ‘hide’ inside cells of people living with HIV on antiretroviral therapy, the major barrier to a cure for HIV. Pembrolizumab is a monoclonal antibody that reverses the ‘exhaustion’ of the […]

Read More
Health News

Gene therapy for the treatment of Huntington’s disease

Credit: Pixabay/CC0 Public Domain Gene therapy targeting the messenger RNA (mRNA) of the mutated huntingtin gene (HTT) can provide long-lasting therapeutic benefit in Huntington’s disease after a single administration. An adeno-associated virus (AAV) gene therapy containing a primary artificial microRNA (pri-amiRNA) targeting HTT mRNA is described in the peer-reviewed journal Human Gene Therapy. “The challenge […]

Read More
Health News

MRI of hand, foot may predict rheumatoid arthritis in undifferentiated arthritis

(HealthDay)—Magnetic resonance imaging (MRI) of the hand and foot may predict rheumatoid arthritis (RA) in patients presenting with undifferentiated arthritis (UA), according to a study published online Jan. 12 in Rheumatology. Nikolet K. den Hollander, M.D., Ph.D., from the Leiden University Medical Center in the Netherlands, and colleagues studied the predictive value of MRI for […]

Read More